cp wire

CP Wire Articles

CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial

CEL-SCI Corporation (NYSE American: CVM) announced on 8/15/18 that the Independent Data Monitoring Committee (IDMC) for the Company's pivotal Phase 3 head and neck cancer study of its... read more

Wed, 08/15/18 - 09:27 am
Onspira Therapeutics' OSP-101 Receives Orphan Drug Designation for Bronchiolitis Obliterans
  • No currently approved drugs for Bronchiolitis Obliterans
  • OSP-101 is the first and only inhaled interleukin-1 receptor antagonist
  • Nearly 80 percent of lung transplant... read more
Tue, 08/14/18 - 10:31 am
Ironshore Pharmaceuticals Books $143 Million with Private Placement

Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., announced on 8/14/18 that it has entered into agreements with purchasers... read more

Tue, 08/14/18 - 10:13 am
iSchemaView's RAPID Technology Now Installed in More Than 500 Stroke Centers
  • 575 stroke centers committed to using the RAPID platform
  • Adoption is up 48% since April
  • Technology recently used in two landmark stroke trials


IschemaView... read more

Tue, 08/14/18 - 09:51 am
Pre-clinical Data Supports Synlogic's Synthetic Biotic as a Potential Treatment for Phenylketonuria



Synlogic, Inc., (Nasdaq: SYBX) announced on 8/13/18 the publication of data from preclinical studies of SYNB1618, the Company’s Synthetic Biotic development program targeting PKU, in... read more

Mon, 08/13/18 - 11:54 pm

Pages